Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: Omicron Update Plus the Latest on Molnupiravir

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

To Download a copy of the Q&A Responses here.

For more information on this topic, please visit the Real Time Learning Network

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here. The agenda and details are below.

Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Topics and Featured Experts:

The Latest on Molnupiravir
Amber Vasquez, MD, MPH
Deputy Taskforce Lead
Healthcare Systems Worker Safety Taskforce
U.S. Centers for Disease Control and Prevention

Omicron Update

Overview
John T. Brooks, MD
Chief Medical Officer
COVID-19 Response
U.S. Centers for Disease Control and Prevention

Viral Surveillance Update
David E. Wentworth, PhD
Lead, Surveillance & Emerging Variants Team
Laboratory and Testing Task Force
COVID-19 Emergency Response
Chief, Virology Surveillance and Diagnosis Branch
U.S. Centers for Disease Control and Prevention

Addressing Diagnostic Challenges
Matthew J. Binnicker, PhD, D(ABMM)
Professor of Laboratory Medicine and Pathology
Vice Chair of Practice, Department of Laboratory Medicine and Pathology
Medical Director, Clinical Virology Laboratory, Division of Clinical Microbiology
Mayo Clinic, Rochester, Minnesota

Q&A and Discussion

Kimberley Fox, MD, MPH
Captain, U.S. Public Health Service
Vaccine Task Force Co-Lead
COVID-19 Response
U.S. Centers for Disease Control and Prevention

Sanjat Kanjilal, MD, MPH
Lecturer, Department of Population Medicine
Harvard Pilgrim Healthcare Institute
Harvard Medical School

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.